EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Leukocyte matrices in personalized immune status assessment of patients with sepsis

Andrei A. Savchenko, Edward V. Kasparov, Sergey A. Borisov, Elena N. Anisimova, Dmitriy V. Cherdantsev, Dmitriy E. Zdzitovetsky, Roman N. Borisov, Dmitriy A. Kochenov, Ekaterina V. Savchenko, Alexandr G. Borisov

Cytokines and inflammation · 10.12.2025 · 22 (3) · 96-103

DOI: 10.17816/ci694031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytokines and inflammation, online erschienen am 10.12.2025. Verfasst von Andrei A. Savchenko und 9 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Being one of the leading causes of mortality, sepsis is a global healthcare and social issue. Sepsis is a life-threatening organ dysfunction caused by dysregulated immune response to infection. The current understanding of its pathophysiology has shifted from studying the pathogen to analyzing the patient’s immune response, which is very different and unique. In general, sepsis is the simultaneous or sequential development of hyperinflammation and immunosuppression, which ultimately determines the clinical outcome. This paper emphasizes the need for a personalized approach to sepsis treatment based on the diagnosis of impaired immune status in the patient. We propose the complete blood count assessment using leukocyte analysis matrices allowing to determine the type and nature of immune response as an accessible, reproducible, and pathogenetically substantiated tool, even in a regular hospital setting. The paper presents a method for interpreting leukocyte matrices using the sepsis immunotyping technology allowing to identify the activation of innate or adaptive immunity and the nonimmunity or immunosuppression state. A conclusion is made on the clinical importance of the proposed approach for predicting the course of the disease, timely therapy correction, and the selection of a balanced, immune-oriented therapy. Thus, clinical integration of this approach contributes to the transition from empirical to pathogenetically substantiated therapy.

Zitieren

APA

Savchenko, A. A., Kasparov, E. V., Borisov, S. A., Anisimova, E. N., Cherdantsev, D. V., Zdzitovetsky, D. E., Borisov, R. N., Kochenov, D. A., Savchenko, E. V., & Borisov, A. G. (2025). Leukocyte matrices in personalized immune status assessment of patients with sepsis. Cytokines and inflammation, 22(3), 96-103. https://doi.org/10.17816/ci694031

Vancouver

Savchenko AA, Kasparov EV, Borisov SA, Anisimova EN, Cherdantsev DV, Zdzitovetsky DE, et al. Leukocyte matrices in personalized immune status assessment of patients with sepsis. Cytokines and inflammation. 2025;22(3):96-103. doi:10.17816/ci694031

BibTeX
@article{Savchenko2025,
  author = {Savchenko, Andrei A. and Kasparov, Edward V. and Borisov, Sergey A. and Anisimova, Elena N. and Cherdantsev, Dmitriy V. and Zdzitovetsky, Dmitriy E. and Borisov, Roman N. and Kochenov, Dmitriy A. and Savchenko, Ekaterina V. and Borisov, Alexandr G.},
  title = {Leukocyte matrices in personalized immune status assessment of patients with sepsis},
  journal = {Cytokines and inflammation},
  year = {2025},
  volume = {22},
  number = {3},
  pages = {96--103},
  doi = {10.17816/ci694031}
}
Kostenlos starten →